BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17979731)

  • 1. Anti-angiogenesis and RGD-containing snake venom disintegrins.
    Swenson S; Ramu S; Markland FS
    Curr Pharm Des; 2007; 13(28):2860-71. PubMed ID: 17979731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical studies of a novel snake venom-derived recombinant disintegrin with antitumor activity: A review.
    Schönthal AH; Swenson SD; Chen TC; Markland FS
    Biochem Pharmacol; 2020 Nov; 181():114149. PubMed ID: 32663453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism.
    Cai W; Chen X
    Anticancer Agents Med Chem; 2006 Sep; 6(5):407-28. PubMed ID: 17017851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contortrostatin, a snake venom disintegrin with anti-angiogenic and anti-tumor activity.
    Swenson S; Costa F; Ernst W; Fujii G; Markland FS
    Pathophysiol Haemost Thromb; 2005; 34(4-5):169-76. PubMed ID: 16707922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potential use of snake venom components in cancer treatment].
    Vivas D; Inga R; Yarlequé A
    Rev Peru Med Exp Salud Publica; 2012; 29(3):396-401. PubMed ID: 23085804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic insights of snake venom disintegrins in cancer treatment.
    Akhtar B; Muhammad F; Sharif A; Anwar MI
    Eur J Pharmacol; 2021 May; 899():174022. PubMed ID: 33727054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Discovery of Snake Venom Disintegrins to A Safer Therapeutic Antithrombotic Agent.
    Kuo YJ; Chung CH; Huang TF
    Toxins (Basel); 2019 Jun; 11(7):. PubMed ID: 31247995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Snake venom disintegrins: classification and therapeutic potential].
    Kallech-Ziri O; Luis J; El Ayeb M; Marrakchi N
    Arch Inst Pasteur Tunis; 2007; 84(1-4):29-37. PubMed ID: 19388581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of Snake Venom Disintegrins in Angiogenesis.
    Clissa PB; Della-Casa MS; Zychar BC; Sanabani SS
    Toxins (Basel); 2024 Mar; 16(3):. PubMed ID: 38535794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disintegrins from snake venoms and their applications in cancer research and therapy.
    Arruda Macêdo JK; Fox JW; de Souza Castro M
    Curr Protein Pept Sci; 2015; 16(6):532-48. PubMed ID: 26031306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumoral Potential of Lansbermin-I, a Novel Disintegrin from Porthidium lansbergii lansbergii Venom on Breast Cancer Cells.
    Montealegre-Sánchez L; Gimenes SNC; Lopes DS; Teixeira SC; Solano-Redondo L; de Melo Rodrigues V; Jiménez-Charris E
    Curr Top Med Chem; 2019; 19(22):2069-2078. PubMed ID: 31385773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression.
    Swenson S; Costa F; Minea R; Sherwin RP; Ernst W; Fujii G; Yang D; Markland FS
    Mol Cancer Ther; 2004 Apr; 3(4):499-511. PubMed ID: 15078994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of an Anti-Tumour Disintegrin: Dabmaurin-1, a Peptide Lebein-1-Like, from
    Chalier F; Mugnier L; Tarbe M; Aboudou S; Villard C; Kovacic H; Gigmes D; Mansuelle P; de Pomyers H; Luis J; Mabrouk K
    Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32033352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of trimestatin, a disintegrin containing a cell adhesion recognition motif RGD.
    Fujii Y; Okuda D; Fujimoto Z; Horii K; Morita T; Mizuno H
    J Mol Biol; 2003 Oct; 332(5):1115-22. PubMed ID: 14499613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-angiogenic activities of two recombinant disintegrins derived from the Mohave and Prairie rattlesnakes.
    Lucena SE; Romo K; Suntravat M; Sánchez EE
    Toxicon; 2014 Feb; 78():10-7. PubMed ID: 24269784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-RGD-containing snake venom disintegrins, functional and structural relations.
    Walsh EM; Marcinkiewicz C
    Toxicon; 2011 Sep; 58(4):355-62. PubMed ID: 21801741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contortrostatin, a homodimeric snake venom disintegrin, is a potent inhibitor of osteoclast attachment.
    Mercer B; Markland F; Minkin C
    J Bone Miner Res; 1998 Mar; 13(3):409-14. PubMed ID: 9525341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Snake venom derived molecules in tumor angiogenesis and its application in cancer therapy; an overview.
    Dhananjaya BL; Sivashankari PR
    Curr Top Med Chem; 2015; 15(7):649-57. PubMed ID: 25714377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression.
    Zhou Q; Sherwin RP; Parrish C; Richters V; Groshen SG; Tsao-Wei D; Markland FS
    Breast Cancer Res Treat; 2000 Jun; 61(3):249-60. PubMed ID: 10966001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel recombinant disintegrin, contortrostatin, as an effective anti-tumor and anti-angiogenic agent.
    Minea R; Swenson S; Costa F; Chen TC; Markland FS
    Pathophysiol Haemost Thromb; 2005; 34(4-5):177-83. PubMed ID: 16707923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.